www.168club.com/news/newsdetail.asp?section=Health&stor -
[Cached Version]
Published on: 8/9/2001
Last Visited: 8/9/2001
The suit seeks a declaration that the Claritin ads violate New Jersey law , injunctive relief to prevent similar misleading advertising by Schering-Plough in the future and a portion of the $10 billion that consumers have spent on the prescription drug since mid-1997 , Tom Sobol , a lead attorney for PAL told Reuters Health.
FROM THE LYCOS NETWORK :
...
Ms. Shellenberger's words were accurate then and are now , Sobol said on Thursday.He noted that there is a high probability that the group will file another suit within the next 60 days.
The point of filing the lawsuit is to in some way deter other pharmaceutical companies from engaging in similar conduct , and hopefully start a dialogue where some more sense could be made of the madness of drug prices in America , Sobol said.Our position is...that the FDA has a regulatory role to fulfill , but that private , civil enforcement actions are also an additional way to make sure that effective and accurate communication happens to American consumers..
We aren't trying to preempt , or in any way affect or comment on , the FDA's role , he added.We're simply trying to pursue other roles that the law not only makes available , but expects will be exercised..
Copyright © 2001 Reuters Limited